Pre-made Dupilumab biosimilar ( Whole mAb, anti-IL4R therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-158
Anti-IL4R therapeutic antibody (Pre-made Dupilumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-IL4R therapeutic antibody (Pre-made Dupilumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||6wgb:AB:CD/6wgj:AB:CD:EF/6wgk:AB:CD:EF:GH/6wgl:AB/6wg8:AB|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Aimmune Therapeutics;Regeneron Pharmaceuticals;Sanofi|
|Conditions Approved||Asthma;Atopic dermatitis;Nasal polyps|
|Conditions Active||Chronic obstructive pulmonary disease;Eosinophilic oesophagitis;Grass pollen hypersensitivity;Peanut hypersensitivity;Urticaria|
|Conditions Discontinued||Allergic asthma|
|Development Tech||VelocImmune Mouse|